JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105413200 on September 10, 2001

J. Biol. Chem., Vol. 276, Issue 48, 45236-45242, November 30, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/48/45236    most recent
M105413200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirono, M.
Right arrow Articles by Yoshioka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirono, M.
Right arrow Articles by Yoshioka, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phospholipase Cbeta 4 and Protein Kinase Calpha and/or Protein Kinase Cbeta I Are Involved in the Induction of Long Term Depression in Cerebellar Purkinje Cells*

Moritoshi HironoDagger §, Takashi Sugiyama§, Yasushi Kishimoto||, Ikuko Sakai**, Takahito MiyazawaDagger Dagger , Masahiro Kishio, Hiroko Inoue, Kazuki Nakao§§, Masayuki IkedaDagger , Shigenori Kawahara||, Yutaka Kirino||, Motoya Katsuki§§, Hidenori Horie**, Yoshihiro Ishikawa**, and Tohru YoshiokaDagger ¶¶

From the Dagger  Department of Molecular Neurobiology, Advanced Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, the  Department of Molecular Neurobiology, School of Human Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa-shi, Saitama 359-1192, the || Laboratory of Neurobiophysics, School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, the ** Department of Physiology, School of Medicine, Yokohama City University, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236-0004, the Dagger Dagger  Department of Neurosurgery, National Defense Medical College, 3-2 Namiki, Tokorozawa-shi, Saitama 359-8513, the §§ Department of DNA Biology and Embryo Engineering, Research Center of Animal Models for Human Diseases, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

Received for publication, June 12, 2001, and in revised form, August 30, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Activation of the type-1 metabotropic glutamate receptor (mGluR1) signaling pathway in the cerebellum involves activation of phospholipase C (PLC) and protein kinase C (PKC) for the induction of cerebellar long term depression (LTD). The PLC and PKC isoforms that are involved in LTD remain unclear, however. One previous study found no change in LTD in PKCgamma -deficient mice, thus, in the present study, we examined cerebellar LTD in PLCbeta 4-deficient mice. Immunohistochemical and Western blot analyses of cerebellum from wild-type mice revealed that PLCbeta 1 was expressed weakly and uniformly, PLCbeta 2 was not detected, PLCbeta 3 was expressed predominantly in caudal cerebellum (lobes 7-10), and PLCbeta 4 was expressed uniformly throughout. In PLCbeta 4-deficient mice, expression of total PLCbeta , the mGluR1-mediated Ca2+ response, and LTD induction were greatly reduced in rostral cerebellum (lobes 1-6). Furthermore, we used immunohistochemistry to localize PKCalpha , -beta I, -beta II, and -gamma in mouse cerebellar Purkinje cells during LTD induction. Both PKCalpha and PKCbeta I were found to be translocated to the plasmamembrane under these conditions. Taken together, these results suggest that mGluR1-mediated activation of PLCbeta 4 in rostral cerebellar Purkinje cells induced LTD via PKCalpha and/or PKCbeta I.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cerebellar long term depression (LTD)1 is produced by associative activation of parallel fiber (PF) and climbing fiber synapses (1-4), which results in co-activation of alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR) and type-1 metabotropic glutamate receptors (mGluR1) in Purkinje cells followed by activation of phospholipase C (PLC) coupled to Gq, hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-trisphosphate (IP3) and diacylglycerol, an increase in the concentration of intracellular Ca2+ ([Ca2+]i), and activation of protein kinase C (PKC; for review, see Ref. 5).

As predicted, mGluR1-deficient mutant mice exhibit impaired cerebellar LTD (6, 7), however, there is no disruption of LTD in PKCgamma -deficient mice (8). These results raise the possibility that disruption of one of the intermediate molecules in the mGluR1 signaling pathway may disrupt LTD. Of the four isoforms of PLC, PLCbeta 1-4 (9, 10), two are abundant in the cerebellum, PLCbeta 3 and PLCbeta 4 (11-13). PLCbeta 3 is expressed predominantly in the caudal half of cerebellar Purkinje cells, whereas PLCbeta 4 is distributed throughout cerebellar Purkinje cells. Fly homologue of PLCbeta 4 has been implicated in transduction of visual information in Drosophila photoreceptors (14, 15), however, the role of PLCbeta 4 in the cerebellum remains unknown. The PLCbeta 4-deficient mice were viable but had a higher mortality rate than wild-type mice, and the body weight of PLCbeta 4-deficient mice was generally less than that of wild-type mice in the early stages of postnatal development, as reported previously (16, 17). The body weight of the PLCbeta 4-deficient mice gradually increased to match wild-type mice 8 weeks after birth. Using a light microscope, no differences were detected in the size of whole cerebellum, lobe size, or Purkinje cell size between PLCbeta 4-deficient and wild-type mice. Anatomical alterations are minimal in mGluR1-deficient mutant mice (6) and cerebellar architecture is also normal in glial fibrillary acidic protein (GFAP)-deficient mutant mice (18). Only one abnormality in the cerebellar anatomy of PLCbeta 4-deficient mice has been reported so far; persistent multiple climbing fiber innervation of Purkinje cells (19), which has also been reported in mGluR1-, GluRdelta 2-, and PKCgamma -deficient but not GFAP-deficient mice (18, 20-22). Eight PKC isozymes (alpha , beta I, beta II, gamma , delta , epsilon , zeta , and eta ) are expressed in the cerebellum, of which six (alpha , beta I, gamma , delta , epsilon , and zeta ) are found in cerebellar Purkinje cells (23-25). Selective expression of a pseudosubstrate PKC inhibitor, PKC inhibitor peptide (Arg19-Val31), in Purkinje cells completely blocked cerebellar LTD (26). Therefore, using PLCbeta 4-deficient mice in the present study, we examined the effects of disruption of PLCbeta 4 on cerebellar LTD and determined which PKC isozymes were essential for the induction of LTD.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Generation of PLCbeta 4-deficient Mice-- Mice with a disruption of the PLCbeta 4 gene were generated in the laboratory of M. Katsuki according to standard methods (27). A genomic clone encoding the PLCbeta 4 catalytic region (denoted the Y region) was isolated to construct a targeting vector in which exons that encode amino acid residues 539-646 were replaced with a neomycin-resistant gene cassette, and a diphtheria toxin fragment A gene was attached to the 3'-end of the targeting vector for negative selection. Embryonic stem cells were transfected with the targeting vector by electroporation and selected with G418 (250 µg/ml) for 8 days. G418-resistant colonies were isolated, and the targeted clones were selected using genomic Southern blot analysis with a probe as illustrated in Fig. 1A. Chimeric mice were generated from frozen C57BL/6J blastocytes injected with the embryonic stem cells after warming (28). Male chimeric mice were mated with C57BL/6J female mice. The tail DNA of offspring was analyzed using Southern blot analysis (Fig. 1B) to identify the genotype or amplified using polymerase chain reaction.

Phospholipase C Assay-- PLC enzymatic activity was quantified in 200 µl of assay mixture containing 150 µM PIP2. The mixture contained 20,000 cpm [3H]PIP2, 1 mM EGTA, 10 mM CaCl2, 0.1% sodium deoxycholate, 1 mg/ml bovine serum albumin, and 50 mM HEPES, pH 6.8. The reaction mixture was incubated at 37 °C and centrifuged (10,000 × g for 30 min) to precipitate the cerebellar homogenate, and the reaction was terminated as previously described (29).

Western Blot Analysis and Immunohistochemistry-- Each lobe of the vermis of the cerebellum from wild-type and PLCbeta 4-deficient mice was homogenized, and 3 µg of protein was separated using 7.5% SDS-polyacrylamide gel electrophoresis. Separated proteins were transferred to a nitrocellulose membrane. The membrane was incubated with anti-PLCbeta 1, -beta 2, -beta 3, or -beta 4 antibodies (1/1000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA) and then with an alkaline-phosphatase-labeled secondary antibody (1/5000 dilution, Promega, Madison, WI). Immunoreacted bands were visualized using ProtoBlot Western blot AP Systems (Promega).

At the third or fourth postnatal week, mice were deeply anesthetized with pentobarbital (4 mg/100 g) and transcardially perfused with 4% phosphate-buffered paraformaldehyde (4 °C, pH 7.4). The brains were immersed in the same fixative for half a day and then embedded in paraffin. Sagittal or coronal paraffin-embedded sections (3-5 µm thick) were prepared for immunohistochemical visualization using a streptavidin-peroxidase reaction (Nichirei Co. Ltd., Japan (30, 31)). As a blocking step, the sections were incubated with 3% H2O2 in distilled water for 10 min and then 10% normal goat serum for 1 h. Affinity-purified rabbit polyclonal primary antibodies against either mouse PLCbeta 3 (1/500), PLCbeta 4 (1/50), PKCalpha (1/100, Life Technologies, Inc., Rockville, MD), PKCbeta I (1/500, Life Technologies, Inc.), PKCbeta II (1/500, Life Technologies, Inc.), or PKCgamma (1/500, Life Technologies, Inc.) were applied to brain sections overnight at 4 °C. Subsequently, sections were incubated with biotin-conjugated goat anti-rabbit immunoglobulin G for 1 h at room temperature (23-26 °C). Sections were then incubated with peroxidase-conjugated streptavidin for 1 h at room temperature. Between each incubation step, the sections were rinsed twice in 0.01 M phosphate-buffered saline, pH 7.4, for 5 min each. The final peroxidase reaction was performed using 0.05% diaminobenzidine and 0.005% H2O2. The same sections were stained with cresyl violet for Nissl staining. For immunohistochemical analysis of PKC isozymes, a fluorescein isothiocyanate-conjugated secondary antibody was used and the immunostained sections were examined using fluorescence microscopy.

Ca2+ Imaging-- Sagittal slices (180-200 µm thick) of cerebellar vermis were prepared from 3- to 5-week-old wild-type and PLCbeta 4-deficient mice using a microslicer (DTK-1000, Dosaka, Japan) and maintained at room temperature in artificial cerebrospinal fluid (ACSF), which consisted of 138.6 mM NaCl, 3.35 mM KCl, 21 mM NaHCO3, 0.6 mM NaH2PO4, 9.9 mM glucose, 2.5 mM CaCl2, and 1 mM MgCl2 and was gassed with a mixture of 95% O2 and 5% CO2 (pH 7.4). The Ca2+ indicator fura-2 (1 mM, Dojin, Japan) was injected into Purkinje cells for 25-45 min through patch pipettes or cerebellar slices were incubated in 10 µM fura-2 AM (Dojin) for 1 h with 0.001% Cremophore EL. The slices were then maintained in ACSF for at least 30 min and transferred to the stage of an Axioplan 2 microscope (Zeiss, Germany). Fluorescence Ca2+ ratio imaging was carried out by excitation of the indicator at 340:380 nm, and paired emission images were acquired using a cooled charge-coupled device camera (C4880, Hamamatsu Photonics, Japan) at 510 nm. Fluorescence images were acquired using a 60× water immersion objective (LUMPlanFI, numerical aperture (NA) 0.90, Olympus, Japan) that efficiently passed 340-nm light, and ratios were determined using a digital image acquisition system and image-processing software (ARGUS 50/CA, Hamamatsu Photonics, Japan).

Electrophysiology-- Whole-cell voltage-clamp recordings were made from visually identified Purkinje cells under Nomarski optics using a 40× water immersion objective (NA 0.75, Zeiss). Patch pipettes (3-4 MOmega ) were filled with intracellular solution containing 150 mM KCH3SO3, 5 mM KCl, 0.3 mM K-EGTA, 5.0 mM sodium HEPES, 3.0 mM Mg-ATP, and 0.4 mM Na-GTP (pH 7.4). Membrane currents were recorded using an EPC-7 amplifier (List Electronics, Darmstadt, Germany) and pCLAMP software (Axon Instruments, Union City, CA), digitized, and stored on a computer disc for off-line analysis. PF-mediated ionotropic-glutamate-receptor-type excitatory postsynaptic currents (EPSCs) were identified based on response properties following paired-pulse stimulation (duration, 50-100 µs; amplitude, 5-15 V) applied via a glass microelectrode with 2- to 3-µm tip diameter, filled with normal ACSF, and placed within the molecular layer in the cerebellar cortex. Paired-pulse stimulation was applied at 0.2 Hz. For measuring PF-evoked EPSCs, bicuculline (10 µM) was added to the ACSF to eliminate gamma -aminobutyric acid (GABA)-mediated postsynaptic currents. Series resistance (8-18 MOmega ) was monitored using a -5-mV hyperpolarizing voltage step after PF stimulation. The series resistance compensation control of the amplitude was set between 60 and 70%. mGluR1-mediated EPSCs were obtained using repetitive, high frequency stimulation (10 pulses at 100 Hz; duration, 180 µs; amplitude, 30 V). To prevent ionotropic glutamate and GABAA receptor responses, 6-cyano-7-nitroquinoxaline-2,3-dione (10 µM), D(-)-2-amino-5-phosphonopentanoic acid (30 µM), and bicuculline (50 µM) were added to the external solution. All physiological experiments were performed at room temperature.

Pharmacological Stimulation-- The experimental protocols for LTD were performed as described previously with slight modification (32, 33). Briefly, sagittal slices (400 µm thick) of cerebellar vermis were prepared from 3- to 5-week-old wild-type and PLCbeta 4-deficient mice using a microslicer and maintained at room temperature in ACSF, including 0.5 µM tetrodotoxin and 1 µM BAPTA-AM, and saturated with 95% O2/5% CO2. To stimulate the cells, each slice was then transferred to a cylinder chamber (phi  35 mm) in medium containing 50 mM KCl and 100 µM glutamate. Five minutes after stimulation, the slices were washed with ACSF for 5 min, followed by fixation with 4% paraformaldehyde. Immunohistochemistry was performed as described under "Western Blot Analysis and Immunohistochemistry."

Statistics-- Data were analyzed using one-way analysis of variance, and statistical significance was determined using a Student's t test or Mann-Whitney U test. Differences were considered significant when P was less than 0.05.

During the course of the present study, the care of the animals conformed to the guidelines established by the Institutional Animal Investigation Committee at the University of Tokyo.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Biochemical and Histological Characterization of Cerebellar PLCbeta -- The total activity of membrane-associated PLC was examined using [3H]PIP2 as a substrate in cerebellar slices from wild-type (n = 4) and PLCbeta 4-deficient mice (n = 5). As shown in Fig. 1C, the total PLC activity in PLCbeta 4-deficient mice was less than 30% of control values in rostral cerebellum and less than 40% in caudal cerebellum. These data suggest that PLCbeta 4 activity in rostral and caudal cerebellum was 70 and 60% of the total PLC activity, respectively. Total PLC activity was found to be 5.6 nmol/mg/min in rostral cerebellum and 4.5 nmol/mg/min in caudal cerebellum.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Generation of PLCbeta 4-deficient mice. A, the targeting vector and the homologous recombination process are shown. The black box represents the targeted exon; the white box under the mutant allele indicates the probe used for Southern blot analysis; A, ApaI; B, BamHI; E, EcoRI; H, HindIII; S, SacI; DT, diphtheria toxin A fragment; neo, neomycin-resistant gene cassette. B, Southern blot analysis for genotyping. Tail DNA was isolated, digested with BamHI, and separated using gel electrophoresis. The DNA was transferred to nylon membranes and hybridized with the probe indicated in A. The 18-kb band was the wild-type allele, and the 9-kb band was the targeted allele. C, PLC activity in rostral and caudal cerebellum from wild-type (n = 4; open bars) and PLCbeta 4-deficient mice (n = 5; solid bars) was assayed for PIP2 hydrolysis. Bars represent mean ± S.E.

Western blot analysis (Fig. 2A) indicates that PLCbeta 1, PLCbeta 3, and PLCbeta 4 were expressed in wild-type mouse cerebellum. PLCbeta 4 protein was not detected in the cerebellum from PLCbeta 4-deficient mice (Fig. 2A), whereas the expression levels of the other PLCbeta isoforms (PLCbeta 1, PLCbeta 2, and PLCbeta 3) were not altered.


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 2.   A, Western blot of cerebellar proteins from wild-type (+/+) and PLCbeta 4-deficient mice (-/-). The PLCbeta 1 and -beta 4 isoforms were expressed evenly throughout the cerebellum of wild-type mice, and PLCbeta 3 was observed primarily in caudal (lobes 7-10) cerebellum. PLCbeta 2 was not detected. B-F, immunohistochemical analyses of whole-brain and cerebellar sections. The whole-brain and cerebellar sections from wild-type mice were immunostained with anti-PLCbeta 4 (B and C) or anti-PLCbeta 3 (D-F) antibodies. Hippocampus did not immunoreact with anti-PLCbeta 4 antibody (B). The lobes of mouse cerebellum were numbered 1-10 as indicated (C). E, a higher power view of the rostral cerebellum (lobes 4 and 5) indicated by box E in D. Purkinje cells exhibited weak PLCbeta 3 immunoreactivity. F, a higher power view of the caudal cerebellum (lobe 7) indicated by box F in D, showing strong PLCbeta 3 immunoreactivity in dendrites and cell bodies of Purkinje cells. Cb, cerebellum; H, hippocampus; OB, olfactory bulb; T, thalamus. Scale bars: 1 mm in B, 500 µm in C and D, and 70 µm in E and F.

Immunohistochemical analysis was performed using an anti-PLCbeta 4 antibody (Fig. 2, B and C). Each of the lobes in the cerebellar slices was numbered from 1 to 10 as shown in Fig. 2C. PLCbeta 4 was expressed uniformly in Purkinje cells in rostral (lobes 1-6) and caudal (lobes 7-10) cerebellum from wild-type mice (Fig. 2C), whereas PLCbeta 3 is more abundant in Purkinje cells in caudal cerebellum from wild-type mice (13, 19; Fig. 2, D-F). No morphological changes were observed in the cerebellum of PLCbeta 4-deficient mice when examined using light microscopy (data not shown).

Normal PF-Purkinje Cell Synaptic Transmission in PLCbeta 4-deficient Mouse Cerebellum-- To examine PF-Purkinje cell synaptic function in PLCbeta 4-deficient mice, we measured the rise and decay time constants of EPSCs, which were calculated using a single-exponential fit (34) and paired-pulse facilitation in acute cerebellar slices. The mean rise time constant was 1.23 ± 0.06 ms (n = 30) and 1.21 ± 0.05 ms (n = 35) in Purkinje cells from wild-type and PLCbeta 4-deficient mice, respectively. The mean decay time constant was 14.1 ± 0.5 ms (n = 30) in wild-type versus 12.8 ± 0.5 ms (n = 35) in PLCbeta 4-deficient Purkinje cells. There was no significant difference in either the rise or decay time constants between wild-type and PLCbeta 4-deficient mice (p > 0.05; Fig. 3, A and B). The PF responses exhibited paired-pulse facilitation (35), which decreased with increasing interpulse intervals in a similar manner in wild-type and PLCbeta 4-deficient mice (Fig. 3C). Therefore, short term plasticity in PF-Purkinje cell synapses appeared normal in PLCbeta 4-deficient mice. Furthermore, no significant difference was found in the resting membrane potentials (-55.5 ± 1.3 mV versus -56.3 ± 1.5 mV) of Purkinje cells from wild-type and PLCbeta 4-deficient mice.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   The mean rise and decay times and paired-pulse facilitation of Purkinje cell synaptic responses were not affected in PLCbeta 4-deficient mice. A-C, PF-EPSCs were unaltered in Purkinje cells from PLCbeta 4-deficient mice. Representative traces showing the response to paired-pulse stimulation in a Purkinje cell from a wild-type mouse (A) and a PLCbeta 4-deficient mouse (B). Each trace is the average of 12 consecutive EPSCs. The holding potential was -60 mV. C, paired-pulse facilitation of PF-EPSCs (expressed as the ratio of the responses to the first and second pulses) in Purkinje cells from wild-type (open circle; n = 10, from six mice) and PLCbeta 4-deficient (solid circle; n = 12, from six mice) mice is plotted as a function of interpulse interval. Data points represent the mean ± S.E.

LTD Was Not Inducible in Rostral Cerebellum from PLCbeta 4-deficient Mice-- LTD of synaptic transmission at PF-Purkinje cell synapses is induced by simultaneous low frequency activation of PF and climbing fibers (1, 3). Climbing fiber stimulation can be replaced by depolarizing Purkinje cells to allow calcium influx through voltage-gated calcium channels (36, 37). We recorded PF-EPSCs from Purkinje cells in cerebellar lobes from wild-type and PLCbeta 4-deficient mice using whole-cell patch clamp and a conjunctive stimulation protocol (CJ) composed of 300 PF stimuli in conjunction with a depolarizing pulse (200 ms, -60 to +20 mV) repeated at 1 Hz. In 21 of 25 Purkinje cells from wild-type mice (lobes 1-10), CJ stimulation depressed the amplitude of PF-EPSCs, and this depression persisted over 30 min after the onset of the stimulation (Fig. 4A). The mean PF-EPSCs amplitude, measured 25-30 min after CJ stimulation, was reduced to 75.8% ± 3.6% (n = 17 from 13 mice, two cells studied blind) of the original baseline EPSC amplitude. Depression could be induced even after 40 min in whole-cell recording configuration, indicating that cell dialysis had no significant effect on LTD induction. In PLCbeta 4-deficient mice, Purkinje cells exhibited reduced LTD after CJ stimulation in rostral cerebellum (lobes 1-6; Fig. 4B), whereas LTD was intact in caudal cerebellum (lobes 7-10; Fig. 4C). The mean amplitude of PF-EPSCs in rostral cerebellum recorded 25-30 min after CJ stimulation was 90.1% ± 5.5% of control (n = 16 from 11 mice, two cells studied blind). The difference between the wild-type and PLCbeta 4-deficient mice was significant (Mann-Whitney U test, p < 0.05) in rostral cerebellum, whereas LTD from caudal cerebellum in PLCbeta 4-deficient mice (67.5% ± 2.5%; n = 11 from 10 mice) was comparable to LTD in wild-type mice (Mann-Whitney U test, p > 0.05).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   LTD of PF-EPSCs was impaired in the rostral cerebellum from PLCbeta 4-deficient mice. The amplitude of PF-EPSCs in Purkinje cells from wild-type (A) and PLCbeta 4-deficient (B and C) mice. Cerebellar LTD in PLCbeta 4-deficient mice was impaired in the rostral cerebellum (lobes 1-6; B), whereas LTD in the caudal cerebellum (lobes 7-10; C) was not different from that observed in wild-type mice. The EPSC was evoked by stimulation of PF at 0.2 Hz throughout the experiments. Depolarization to +20 mV for 200 ms was applied 300 times in conjunction with PF stimulation (CJ) over 5 min as indicated by the bar. Traces are averages of 10 individual EPSCs recorded before (1) and 25 min after (2) CJ stimulation. Data points represent the mean ± S.E.

Determination of the PKC Isozymes Activated by PLCbeta 4-- PKC isozymes in Purkinje cells from PLCbeta 4-deficient mice were examined as a function of mGluR1-mediated IP3-dependent Ca2+ mobilization. Only classic PKC isozymes (alpha , beta I, beta II, and gamma ) can be activated by IP3-activated Ca2+ release and diacylglycerol (38). Although application of the mGluR1-specific agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) has been shown to increase [Ca2+]i in rodent cerebellar Purkinje cells (39; Fig. 5K), in the present study in PLCbeta 4-deficient mice, DHPG did not induce Ca2+ mobilization (n = 3; Fig. 5, C and E) in lobe 6 Purkinje cells but increased dendritic [Ca2+]i to a small degree in lobe 9 Purkinje cells (n = 4; Fig. 5, H and J). To exclude the possibility that the lack of Ca2+ release in the mutant mice was an artifact of slice preparation, we examined AMPAR-induced Ca2+ release after DHPG stimulation. Application of AMPA evoked a large Ca2+ transient in Purkinje cells in wild-type cerebellum (Fig. 5K). As shown in Fig. 5 (E and J), large Ca2+ responses were also obtained in Purkinje cells in rostral and caudal cerebellum from PLCbeta 4-deficient mice following application of AMPA. There was an additional slow phase of the AMPA-induced Ca2+ response in the dendrite (Fig. 5, E, J, and K), which may be due to Ca2+ signals traveling from distal parts of the dendrite. In the soma, however, the two phases overlapped. These results suggest that classic PKC isozymes were not activated in rostral cerebellum from PLCbeta 4-deficient mice.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 5.   Lack of DHPG-induced Ca2+ mobilization in Purkinje cells of rostral cerebellum of PLCbeta 4-deficient mice. A and F, representative fluorescence images (380-nm excitation wavelength) before application of DHPG. The red and black boxes indicate the position where the Ca2+ level was measured in the dendrites and soma, respectively. Pseudocolor ratio images at the time indicated (B-D, G-I). The time course of changes in F340/F380 ratio (E, J, and K). The application of DHPG (30 µM, 30 s) did not induce an increase in [Ca2+]i in Purkinje cells in lobe 6, whereas a small rise was observed in lobe 9 from PLCbeta 4-deficient mice. Purkinje cells were voltage-clamped at a holding potential of -60 mV. Changes in [Ca2+]i in response to an application of AMPA (10 µM, 30 s) were unaltered. Both DHPG and AMPA produced Ca2+ elevations in Purkinje cells in lobe 6 from wild-type mice (K). L and M, average F340/F380 values during stimulation with DHPG (L) or AMPA (M) in Purkinje cells from wild-type and PLCbeta 4-deficient mice. Fluorescence of Purkinje cells in cerebellar slices loaded with fura-2 AM was recorded in the presence of tetrodotoxin (0.5 µM). The numbers in parentheses indicate the number of Purkinje cells tested. Bars represent mean ± S.E. **, p < 0.01.

To investigate possible colocalization of classic PKC isozymes with PLCbeta 4, we examined the distribution of classic PKC isozymes using antibodies against each isozyme. Immunostaining with antibodies were done as described under "Experimental Procedure." As shown in Fig. 6 (A-D), PKCalpha , beta I, and gamma  were expressed uniformly in Purkinje cells, whereas PKCbeta II was not detected. These data are consistent with data obtained previously by several authors (23, 25). To investigate the PKC isozymes coupled to PLCbeta 4 and PLCbeta 3, we examined the translocation of PKC isozymes during LTD induction using immunohistochemistry. Fluorescence-labeled secondary antibodies were used in this experiment, because fluorescent images showed a relatively large difference between wild-type and PLCbeta 4-deficient mice with high contrast. 400-µm cerebellar slices from wild-type (n = 8 from four mice) and PLCbeta 4-deficient mice (n = 8 from four mice) were incubated for 5 min in ACSF with (n = 4 of each mice) or without (n = 4 of each mice) 100 µM glutamate and 50 mM KCl. After stimulation, samples were rinsed for 5 min, followed by fixation. From 10 to 15 sections (5-µm thickness) from each slice were stained with antibodies. In wild-type mice, there was strong staining for PKCalpha in the dendrites of Purkinje cells (Fig. 6F), indicating that PKCalpha is translocated. In contrast, no stain was detected in dendrites in PLCbeta 4-deficient mice (Fig. 6G). PKCbeta I immunoreactivity was very strong in Purkinje cell dendrites and soma in all lobes of wild-type mice (Fig. 6I), whereas the fluorescent signal was observed only in cell somas in rostral part of PLCbeta 4-deficient mice (Fig. 6J). No difference in staining for PKCgamma , however, was detectable between wild-type and PLCbeta 4-deficient mice (Fig. 6, L and M).


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 6.   Localization of PKC isozymes in Purkinje cells after application of the LTD-inducing stimulation paradigm. Cerebellar sections from wild-type mice were immunostained with anti-PKCalpha (A), -beta I (B), -beta II (C), or -gamma (D) antibodies. Purkinje cells exhibited intense and uniform PKCalpha , -beta I, and -gamma immunoreactivity. PKCbeta II was present only in the granule cell layer. Fluorescence images show PKC isozymes after LTD induction in rostral cerebellum. Unstimulated (stim.(-); E, H, and K) and stimulated (stim.(+); F, G, I, J, L, M) cerebellar slices were stained with anti-PKCalpha (E-G), anti-PKCbeta I (H-J), or anti-PKCgamma antibody (K-M). PKCalpha immunoreactivity appeared in Purkinje cell dendrites and soma in wild-type (+/+) mice 5 min after stimulation (F), whereas only cell somas were stained in PLCbeta 4-deficient (-/-) mice (G). PKCbeta I immunoreactivity was observed in Purkinje cell dendrites in wild-type (+/+) mice (I) with LTD stimulation, whereas no immunoreactivity was observed in dendrites in PLCbeta 4-deficient (-/-) mice (J). Fluorescence images of Purkinje cells were not different between wild-type (L) and PLCbeta 4-deficient mice (M) when using anti-PKCgamma antibody. Bar = 100 µm in A-D and 50 µm in E-M.

Unfortunately, we could not determine the coupling selectivity between PLC (beta 3 and beta 4) and PKC (alpha  and beta I), because imaging of PKC in caudal part is not clear (data not shown). To overcome this difficulty, a real time imaging of GFP-labeled PKC in living cells under LTD condition is desirable, but it is impossible at present stage. Therefore, we concluded that, at the lowest estimate, both PKCalpha and PKCbeta I were translocated during LTD induction, but PKCgamma was not.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present study, the mGluR1-mediated Ca2+ response and LTD induction was greatly reduced in the rostral cerebellum from PLCbeta 4-deficient mice, an area in which PLCbeta 1 and PLCbeta 3 were also not expressed strongly in these mutant mice. In the caudal cerebellum, however, the residual PLCbeta 3 activity was sufficient to generate Ca2+ elevation and LTD induction. These results suggest that there was a minimum level of PLCbeta 3 and PLCbeta 4 required to generate the mGluR1-mediated Ca2+ response and LTD. We also showed that LTD induction in rostral and caudal cerebellum required activation of classic PKC isozymes.

Differential Functional Localization of PLCbeta Isoforms and Intracellular Ca2+ Elevation-- We used immunohistochemical and Western blot analyses to localize the PLCbeta isoforms in the wild-type mouse cerebellum: PLCbeta 1 was expressed uniformly and weakly, PLCbeta 2 was not detected, PLCbeta 3 was expressed predominantly in caudal cerebellar Purkinje cells (lobes 7-10), and PLCbeta 4 was expressed uniformly and strongly throughout cerebellar Purkinje cells. These results are consistent with previous reports of expression of the corresponding PLCbeta isoform mRNA (11-13). In PLCbeta 4-deficient mice, Although PLCbeta 1 was expressed in rostral cerebellar Purkinje cells, Purkinje cells in rostral cerebellum from PLCbeta 4-deficient mice lacked the mGluR1-mediated Ca2+ response. These results indicate that (i) PLCbeta 1 is not involved in the mGluR1-mediated signaling pathway in cerebellar Purkinje cells and does not have a role in the induction of cerebellar LTD and (ii) mGluR1-mediated responses in caudal cerebellar Purkinje cells from PLCbeta 4-deficient mice were produced by activation of PLCbeta 3 alone. These results suggest that PLCbeta 4 is a link between the activation of mGluR1 and the induction of LTD in rostral cerebellar Purkinje cells.

Involvement of PKC Isozymes in the Formation of LTD-- The results of the present study showing that LTD induction was greatly reduced in PLCbeta 4-deficient mice is consistent with the lack of LTD in cerebellum from mGluR1-deficient mice (6, 7) but does not appear to be consistent with the intact LTD induction observed in PKCgamma -deficient mice (8) if PLCbeta 4 activates PKCgamma . Recent evidence using the expression of a PKC inhibitor in Purkinje cells indicates that PKC is required for LTD induction (26). PKCalpha , beta I, and gamma  were expressed strongly and uniformly in cerebellar Purkinje cells, whereas PKCbeta II was not expressed in Purkinje cells as shown in Fig. 6 (A-D) (25). PKCdelta , epsilon , and zeta  were also expressed in cerebellar Purkinje cells (23); however, these isozymes are Ca2+-independent (for review, see Ref. 38), thus, the contribution of these isozymes to LTD induction is likely to be small. Therefore, the remaining isozymes, PKCalpha and/or PKCbeta I, may compensate for the lack of PKCgamma in rostral cerebellum of PKCgamma -deficient mice.

In PLCbeta 4-deficient mice, there did not appear to be any compensation for the lack of PLCbeta 4 by PLCbeta 1 in the rostral cerebellum. Thus, evidence suggests that, although compensation for deletion of protein isoforms in the signaling pathway downstream of PLCbeta occurs, there is no compensatory mechanism for the deletion of PLCbeta 4 itself.

Select PKC Translocation during LTD Induction-- Translocation of PKC isozymes after 12-O-tetradecanoylphorbol-13-acetate (TPA) stimulation has been clearly observed in several cell systems (40-44) but not with stimulation sufficient for LTD induction. As described above, the combination of PLC (beta 3 and beta 4) activation and translocation of PKC (alpha  and beta I) is very likely. Translocation of PKCgamma has been observed after stimulation used to induce long term potentiation in neurons in the CA1 region of hippocampus (45, 46) and TPA stimulation in COS-7 cells (43) but not by LTD-forming conditions in Purkinje cells in the present study. This is consistent with previous results from PKCgamma -deficient mice (8). This result further indicates that PKCgamma was not activated by the signaling pathway through PLCbeta 3 and PLCbeta 4 in cerebellar Purkinje cells.

It has been reported that Purkinje cells in rostral cerebellum from PLCbeta 4-deficient mice form persistent multiple synapses with climbing fibers (19). This difference may underlie the lack of LTD induction in PLCbeta 4-deficient mice, however, Chen et al. (8) report that, in PKCgamma -deficient mice also, each climbing fiber forms multiple synapses with Purkinje cells and generates multiple spikes that resemble complex spikes, and these mice do exhibit LTD. Thus, the persistent multiple innervation of Purkinje cells by climbing fibers in rostral cerebellum of PLCbeta 4-deficient mice does not appear to be involved in LTD induction. Moreover, eye blink conditioning is impaired in PLCbeta 4-deficient mice (47). The results from the present study support the idea that induction of LTD has a role in eye blink conditioning, but the developmental shift from multiple to mono-innervation of Purkinje cells by climbing fibers does not have a role in either LTD induction or eye blink conditioning. These ideas are expressed in Fig. 7 as a molecular linkage of mGluR1-Gq-PLCbeta 4-PKCalpha and/or PKCbeta I.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7.   Model of the mGluR1 signaling pathway involved in cerebellar LTD induction and eye blink conditioning. PLCbeta 4, PKCalpha , and PKCbeta I have major roles in LTD induction in rostral cerebellum.

Taken together, the results obtained in the present study provide strong support for the idea that cerebellar LTD involves PKC activation. Further studies are needed to determine if the signaling pathway involves more specific combinations between signaling molecules, such as mGluR1-Gq-PLCbeta 4-PKCalpha or mGluR1-Gq-PLCbeta 3-PKCbeta I.

    ACKNOWLEDGEMENTS

We thank S. Konishi, A. Aiba, K. Nakamura, and H. Kojima for their expert technical advice, and C. N. Allen for critically reading the manuscript.

    FOOTNOTES

* This work was supported by a Grant-in-Aid (0727910 to T. Y.) for Scientific Research on Priority Areas on "Functional Development of Neural Circuits" from the Ministry of Education, Science, Sports and Culture of Japan; by Research for the Future Program (96L00310 to T. Y.); a Grant-in-Aid (12780603 to M. H.) for Encouragement of Young Scientists from Japan Society for the Promotion of Science; and by a grant from the Program for Promotion of Basic Research Activity for Innovative Bioscience.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

¶¶ To whom correspondence should be addressed: Tel./Fax: 81-3-3205-6419; E-mail: yoshioka@human.waseda.ac.jp.

Published, JBC Papers in Press, September 10, 2001, DOI 10.1074/jbc.M105413200

    ABBREVIATIONS

The abbreviations used are: LTD, long term depression; PF, parallel fiber; AMPA, alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; mGluR, metabotropic glutamate receptor; PLC, phospholipase C; PIP2, phosphatidylinositol 4,5-bisphosphate; IP3, inositol 1,4,5-trisphosphate; [Ca2+]i, intracellular Ca2+; PKC, protein kinase C; ACSF, artificial cerebrospinal fluid; EPSC, excitatory postsynaptic current; GABA, gamma -aminobutyric acid; GFAP, glial fibrillary acidic protein; CJ, conjunctive stimulation protocol; DHPG, (RS)-3,5-dihydroxyphenylglycine; TPA, 12-O-tetradecanoylphorbol-13-acetate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ito, M., Sakurai, M., and Tongroach, P. (1982) J. Physiol. 324, 113-134
2. Ekerot, C. F., and Kano, M. (1985) Brain Res. 342, 357-360
3. Sakurai, M. (1987) J. Physiol. 394, 463-480
4. Kim, J. J., and Thompson, R. F. (1997) Trends Neurosci. 20, 177-181
5. Linden, D. J., and Connor, J. A. (1995) Annu. Rev. Neurosci. 18, 319-357
6. Aiba, A., Kano, M., Chen, C., Stanton, M. E., Fox, G. D., Herrup, K., Zwingman, T. A., and Tonegawa, S. (1994) Cell 79, 377-388
7. Conquet, F., Bashir, Z. I., Davies, C. H., Daniel, H., Ferraguti, F., Bordi, F., Franz-Bacon, K., Reggiani, A., Matarese, V., and Conde, F. (1994) Nature 372, 237-243
8. Chen, C., Kano, M., Abeliovich, A., Chen, L., Bao, S., Kim, J. J., Hashimoto, K., Thompson, R. F., and Tonegawa, S. (1995) Cell 83, 1233-1242
9. Cockcroft, S., and Thomas, G. M. (1992) Biochem. J. 288, 1-14
10. Rhee, S. G., and Bae, Y. S. (1997) J. Biol. Chem. 272, 15045-15048
11. Tanaka, O., and Kondo, H. (1994) Neurosci. Lett. 182, 17-20
12. Roustan, P., Abitbol, M., Menini, C., Ribeaudeau, F., Gerard, M., Vekemans, M., Mallet, J., and Dufier, J. L. (1995) Neuroreport 6, 1837-1841
13. Watanabe, M., Nakamura, M., Sato, K., Kano, M., Simon, M. I., and Inoue, Y. (1998) Eur. J. Neurosci. 10, 2016-2025
14. Yoshioka, T., Inoue, H., Kasama, T., Seyama, Y., Nakashima, S., Nozawa, Y., and Hotta, Y. (1985) J. Biochem. (Tokyo) 98, 657-662
15. Kim, M. J., Bahk, Y. Y., Min, D. S., Lee, S. J., Ryu, S. H., and Suh, P. G. (1993) Biochem. Biophys. Res. Commun. 194, 706-712
16. Jiang, H., Lyubarsky, A., Dodd, R., Vardi, N., Pugh, E., Baylor, D., Simon, M. I., and Wu, D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14598-14601
17. Kim, D., Jun, K. S., Lee, S. B., Kang, N. G., Min, D. S., Kim, Y. H., Ryu, S. H., Suh, P. G., and Shin, H. S. (1997) Nature 389, 290-293
18. Shibuki, K., Gomi, H., Chen, L., Bao, S., Kim, J. J., Wakatsuki, H., Fujisaki, T., Fujimoto, K., Katoh, A., Ikeda, T., Chen, C., Thompson, R. F., and Itohara, S. (1996) Neuron 16, 587-599
19. Kano, M., Hashimoto, K., Watanabe, M., Kurihara, H., Offermanns, S., Jiang, H., Wu, Y., Jun, K., Shin, H. S., Inoue, Y., Simon, M. I., and Wu, D. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 15724-15729
20. Kano, M., Hashimoto, K., Kurihara, H., Watanabe, M., Inoue, Y., Aiba, A., and Tonegawa, S. (1997) Neuron 18, 71-79
21. Kashiwabuchi, N., Ikeda, K., Araki, K., Hirano, T., Shibuki, K., Takayama, C., Inoue, Y., Kutsuwada, T., Yagi, T., and Kang, Y. (1995) Cell 81, 245-252
22. Kano, M., Hashimoto, K., Chen, C., Abeliovich, A., Aiba, A., Kurihara, H., Watanabe, M., Inoue, Y., and Tonegawa, S. (1995) Cell 83, 1223-1231
23. Wetsel, W. C., Khan, W. A., Merchenthaler, I., Rivera, H., Halpern, A. E., Phung, H. M., Negro-Vilar, A., and Hannun, Y. A. (1992) J. Cell Biol. 117, 121-133
24. Chen, S., and Hillman, D. E. (1993) Neuroscience 56, 177-188
25. Garcia, M. M., and Harlan, R. E. (1997) J. Comp. Neurol. 385, 26-42
26. De Zeeuw, C. I., Hansel, C., Bian, F., Koekkoek, S. K., van Alphen, A. M., Linden, D. J., and Oberdick, J. (1998) Neuron 20, 495-508
27. Capecchi, M. R. (1989) Science 244, 1288-1292
28. Nakao, K., Nakagata, N., and Katsuki, M. (1998) Exp. Anim. (Tokyo) 47, 167-171
29. Min, D. S., Kim, D. M., Lee, Y. H., Seo, J., Suh, P. G., and Ryu, S. H. (1993) J. Biol. Chem. 268, 12207-12212
30. Guesdon, J. L., Ternynck, T., and Avrameas, S. (1979) J. Histochem. Cytochem. 27, 1131-1139
31. Warnke, R., and Levy, R. (1980) J. Histochem. Cytochem. 28, 771-776
32. Nakazawa, K., Mikawa, S., Hashikawa, T., and Ito, M. (1995) Neuron 15, 697-709
33. Murashima, M., and Hirano, T. (1999) J. Neurosci. 19, 7326-7333
34. Llano, I., Marty, A., Armstrong, C. M., and Konnerth, A. (1991) J. Physiol. 434, 183-213
35. Konnerth, A., Llano, I., and Armstrong, C. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2662-2665
36. Crepel, F., and Krupa, M. (1988) Brain Res. 458, 397-401
37. Hirano, T. (1990) Neurosci. Lett. 119, 145-147
38. Nishizuka, Y. (1995) FASEB J. 9, 484-496
39. Netzeband, J. G., Parsons, K. L., Sweeney, D. D., and Gruol, D. L. (1997) J. Neurophysiol. 78, 63-75
40. Staak, S., Behnisch, T., and Angenstein, F. (1995) Brain Res. 682, 55-62
41. Sena, C. M., Rosario, L. M., Parker, P. J., Patel, V., and Boarder, M. R. (1996) J. Neurochem. 66, 1086-1094
42. Son, H., Madelian, V., and Carpenter, D. O. (1996) Brain Res. 739, 282-292
43. Sakai, N., Sasaki, K., Ikegaki, N., Shirai, Y., Ono, Y., and Saito, N. (1997) J. Cell Biol. 139, 1465-1476
44. Buchner, K., Adamec, E., Beermann, M. L., and Nixon, R. A. (1999) Brain Res. Mol. Brain Res. 64, 222-235
45. Van der Zee, E. A., Luiten, P. G., and Disterhoft, J. F. (1997) Prog. Neuropsychopharmacol. Biol. Psychiatry 21, 531-572
46. Angenstein, F., Riedel, G., Reyman, K. G., and Staak, S. (1999) Neuroscience 93, 1289-1295
47. Kishimoto, Y., Hirono, M., Sugiyama, T., Kawahara, S., Nakao, K., Kishio, M., Katsuki, M., Yoshioka, T., and Kirino, Y. (2001) Neuroreport, in press


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
G. Maussion, J. Carayol, A.-M. Lepagnol-Bestel, F. Tores, Y. Loe-Mie, U. Milbreta, F. Rousseau, K. Fontaine, J. Renaud, J.-M. Moalic, et al.
Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism
Hum. Mol. Genet., August 15, 2008; 17(16): 2541 - 2551.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Mizutani, Y. Kuroda, A. Futatsugi, T. Furuichi, and K. Mikoshiba
Phosphorylation of Homer3 by Calcium/Calmodulin-Dependent Kinase II Regulates a Coupling State of Its Target Molecules in Purkinje Cells
J. Neurosci., May 14, 2008; 28(20): 5369 - 5382.
[Abstract] [Full Text] [PDF]


Home page
Chem SensesHome page
T. Toyono, S. Kataoka, Y. Seta, and K. Toyoshima
Expression of Phospholipase C-{beta}4 in Rat Circumvallate Taste Buds
Chem Senses, January 1, 2005; 30(suppl_1): i27 - i28.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/48/45236    most recent
M105413200v1